Global and Japan Eye Drug Market Insights, Forecast to 2026

Global and Japan Eye Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Eye Drug Product Introduction
1.2 Market Segments
1.3 Key Eye Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Eye Drug Market Size Growth Rate by Type
1.4.2 Drops
1.4.3 Tablet & Capsule
1.5 Market by Application
1.5.1 Global Eye Drug Market Size Growth Rate by Application
1.5.2 Glaucoma
1.5.3 Retinal Disease
1.5.4 Bacterial?Infection
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Eye Drug Market Size, Estimates and Forecasts
2.1.1 Global Eye Drug Revenue 2015-2026
2.1.2 Global Eye Drug Sales 2015-2026
2.2 Global Eye Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Eye Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Eye Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Eye Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Eye Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Eye Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Eye Drug Revenue Forecast by Region (2021-2026)
3 Global Eye Drug Competitor Landscape by Players
3.1 Global Top Eye Drug Sales by Manufacturers
3.1.1 Global Eye Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Eye Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Eye Drug Manufacturers by Revenue
3.2.1 Global Eye Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Eye Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Eye Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Eye Drug Revenue in 2019
3.2.5 Global Eye Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Eye Drug Price by Manufacturers
3.4 Global Eye Drug Manufacturing Base Distribution, Product Types
3.4.1 Eye Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Eye Drug Product Type
3.4.3 Date of International Manufacturers Enter into Eye Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Eye Drug Market Size by Type (2015-2020)
4.1.1 Global Eye Drug Sales by Type (2015-2020)
4.1.2 Global Eye Drug Revenue by Type (2015-2020)
4.1.3 Eye Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Eye Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Eye Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Eye Drug Revenue Forecast by Type (2021-2026)
4.2.3 Eye Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Eye Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Eye Drug Market Size by Application (2015-2020)
5.1.1 Global Eye Drug Sales by Application (2015-2020)
5.1.2 Global Eye Drug Revenue by Application (2015-2020)
5.1.3 Eye Drug Price by Application (2015-2020)
5.2 Eye Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Eye Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Eye Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Eye Drug Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Eye Drug Market Size YoY Growth 2015-2026
6.1.1 Japan Eye Drug Sales YoY Growth 2015-2026
6.1.2 Japan Eye Drug Revenue YoY Growth 2015-2026
6.1.3 Japan Eye Drug Market Share in Global Market 2015-2026
6.2 Japan Eye Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Eye Drug Players by Sales (2015-2020)
6.2.2 Japan Top Eye Drug Players by Revenue (2015-2020)
6.3 Japan Eye Drug Historic Market Review by Type (2015-2020)
6.3.1 Japan Eye Drug Sales Market Share by Type (2015-2020)
6.3.2 Japan Eye Drug Revenue Market Share by Type (2015-2020)
6.3.3 Japan Eye Drug Price by Type (2015-2020)
6.4 Japan Eye Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Eye Drug Sales Forecast by Type (2021-2026)
6.4.2 Japan Eye Drug Revenue Forecast by Type (2021-2026)
6.4.3 Japan Eye Drug Price Forecast by Type (2021-2026)
6.5 Japan Eye Drug Historic Market Review by Application (2015-2020)
6.5.1 Japan Eye Drug Sales Market Share by Application (2015-2020)
6.5.2 Japan Eye Drug Revenue Market Share by Application (2015-2020)
6.5.3 Japan Eye Drug Price by Application (2015-2020)
6.6 Japan Eye Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Eye Drug Sales Forecast by Application (2021-2026)
6.6.2 Japan Eye Drug Revenue Forecast by Application (2021-2026)
6.6.3 Japan Eye Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Eye Drug Market Size YoY Growth 2015-2026
7.2 North America Eye Drug Market Facts & Figures by Country
7.2.1 North America Eye Drug Sales by Country (2015-2020)
7.2.2 North America Eye Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Eye Drug Market Size YoY Growth 2015-2026
8.2 Europe Eye Drug Market Facts & Figures by Country
8.2.1 Europe Eye Drug Sales by Country
8.2.2 Europe Eye Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Eye Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Eye Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Eye Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Eye Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Eye Drug Market Size YoY Growth 2015-2026
10.2 Latin America Eye Drug Market Facts & Figures by Country
10.2.1 Latin America Eye Drug Sales by Country
10.2.2 Latin America Eye Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Eye Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Eye Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Eye Drug Sales by Country
11.2.2 Middle East and Africa Eye Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Eye Drug Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Eye Drug Products Offered
12.2.5 Novartis Recent Development
12.3 bausch Lomb
12.3.1 bausch Lomb Corporation Information
12.3.2 bausch Lomb Description and Business Overview
12.3.3 bausch Lomb Sales, Revenue and Gross Margin (2015-2020)
12.3.4 bausch Lomb Eye Drug Products Offered
12.3.5 bausch Lomb Recent Development
12.4 Laboratoire Riva
12.4.1 Laboratoire Riva Corporation Information
12.4.2 Laboratoire Riva Description and Business Overview
12.4.3 Laboratoire Riva Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Laboratoire Riva Eye Drug Products Offered
12.4.5 Laboratoire Riva Recent Development
12.5 Jamp Pharma
12.5.1 Jamp Pharma Corporation Information
12.5.2 Jamp Pharma Description and Business Overview
12.5.3 Jamp Pharma Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Jamp Pharma Eye Drug Products Offered
12.5.5 Jamp Pharma Recent Development
12.6 Fresenius
12.6.1 Fresenius Corporation Information
12.6.2 Fresenius Description and Business Overview
12.6.3 Fresenius Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Fresenius Eye Drug Products Offered
12.6.5 Fresenius Recent Development
12.7 Teva Pharmaceutical?
12.7.1 Teva Pharmaceutical? Corporation Information
12.7.2 Teva Pharmaceutical? Description and Business Overview
12.7.3 Teva Pharmaceutical? Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Teva Pharmaceutical? Eye Drug Products Offered
12.7.5 Teva Pharmaceutical? Recent Development
12.8 SANDOZ
12.8.1 SANDOZ Corporation Information
12.8.2 SANDOZ Description and Business Overview
12.8.3 SANDOZ Sales, Revenue and Gross Margin (2015-2020)
12.8.4 SANDOZ Eye Drug Products Offered
12.8.5 SANDOZ Recent Development
12.9 Greenstone
12.9.1 Greenstone Corporation Information
12.9.2 Greenstone Description and Business Overview
12.9.3 Greenstone Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Greenstone Eye Drug Products Offered
12.9.5 Greenstone Recent Development
12.10 Mylan
12.10.1 Mylan Corporation Information
12.10.2 Mylan Description and Business Overview
12.10.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Mylan Eye Drug Products Offered
12.10.5 Mylan Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Eye Drug Products Offered
12.11.5 Pfizer Recent Development
12.12 Mint Pharmaceuticals
12.12.1 Mint Pharmaceuticals Corporation Information
12.12.2 Mint Pharmaceuticals Description and Business Overview
12.12.3 Mint Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Mint Pharmaceuticals Products Offered
12.12.5 Mint Pharmaceuticals Recent Development
12.13 Laboratoires Thea
12.13.1 Laboratoires Thea Corporation Information
12.13.2 Laboratoires Thea Description and Business Overview
12.13.3 Laboratoires Thea Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Laboratoires Thea Products Offered
12.13.5 Laboratoires Thea Recent Development
12.14 Taj Pharmaceuticals
12.14.1 Taj Pharmaceuticals Corporation Information
12.14.2 Taj Pharmaceuticals Description and Business Overview
12.14.3 Taj Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Taj Pharmaceuticals Products Offered
12.14.5 Taj Pharmaceuticals Recent Development
12.15 Actavis
12.15.1 Actavis Corporation Information
12.15.2 Actavis Description and Business Overview
12.15.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Actavis Products Offered
12.15.5 Actavis Recent Development
12.16 APOTEX
12.16.1 APOTEX Corporation Information
12.16.2 APOTEX Description and Business Overview
12.16.3 APOTEX Sales, Revenue and Gross Margin (2015-2020)
12.16.4 APOTEX Products Offered
12.16.5 APOTEX Recent Development
12.17 Sun Pharma
12.17.1 Sun Pharma Corporation Information
12.17.2 Sun Pharma Description and Business Overview
12.17.3 Sun Pharma Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Sun Pharma Products Offered
12.17.5 Sun Pharma Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Eye Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Eye Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Eye Drug Market Segments
Table 2. Ranking of Global Top Eye Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Eye Drug Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Drops
Table 5. Major Manufacturers of Tablet & Capsule
Table 6. Global Eye Drug Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Eye Drug Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Eye Drug Sales by Regions 2015-2020 (MT)
Table 9. Global Eye Drug Sales Market Share by Regions (2015-2020)
Table 10. Global Eye Drug Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Eye Drug Sales Forecast by Region (2021-2026) (MT)
Table 12. Global Eye Drug Sales by Manufacturers (2015-2020) (MT)
Table 13. Global Eye Drug Sales Share by Manufacturers (2015-2020)
Table 14. Global Eye Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Eye Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eye Drug as of 2019)
Table 16. Eye Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Eye Drug Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Eye Drug Price (2015-2020) (USD/Kg)
Table 19. Eye Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Eye Drug Product Type
Table 21. Date of International Manufacturers Enter into Eye Drug Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Eye Drug Sales by Type (2015-2020) (MT)
Table 24. Global Eye Drug Sales Share by Type (2015-2020)
Table 25. Global Eye Drug Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Eye Drug Revenue Share by Type (2015-2020)
Table 27. Eye Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 28. Global Eye Drug Sales Share by Type (2021-2026)
Table 29. Global Eye Drug Sales by Application (2015-2020) (MT)
Table 30. Global Eye Drug Sales Share by Application (2015-2020)
Table 31. Global Eye Drug Sales Share by Application (2021-2026)
Table 32. Global Eye Drug Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Eye Drug Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Eye Drug Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Eye Drug Sales (MT) of Key Companies (2015-2020)
Table 36. Japan Eye Drug Sales Share by Company (2015-2020)
Table 37. Japan Eye Drug Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Eye Drug Sales (MT) by Type (2015-2020)
Table 39. Japan Eye Drug Sales Share by Type (2015-2020)
Table 40. Japan Eye Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Eye Drug Price (MT) by Type (2015-2020)
Table 42. Japan Eye Drug Sales (MT) by Type (2021-2026)
Table 43. Japan Eye Drug Sales Share by Type (2021-2026)
Table 44. Japan Eye Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Eye Drug Revenue Share by Type (2021-2026)
Table 46. Japan Eye Drug Price (MT) by Type (2021-2026)
Table 47. Japan Eye Drug Sales (MT) by Application (2015-2020)
Table 48. Japan Eye Drug Sales Share by Application (2015-2020)
Table 49. Japan Eye Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Eye Drug Sales (MT) by Application (2021-2026)
Table 51. Japan Eye Drug Sales Share by Application (2021-2026)
Table 52. Japan Eye Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Eye Drug Revenue Share by Application (2021-2026)
Table 54. North America Eye Drug Sales by Country (2015-2020) (MT)
Table 55. North America Eye Drug Sales Market Share by Country (2015-2020)
Table 56. North America Eye Drug Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Eye Drug Revenue Market Share by Country (2015-2020)
Table 58. Europe Eye Drug Sales by Country (2015-2020) (MT)
Table 59. Europe Eye Drug Sales Market Share by Country (2015-2020)
Table 60. Europe Eye Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Eye Drug Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Eye Drug Sales by Region (2015-2020) (MT)
Table 63. Asia Pacific Eye Drug Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Eye Drug Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Eye Drug Revenue Market Share by Region (2015-2020)
Table 66. Latin America Eye Drug Sales by Country (2015-2020) (MT)
Table 67. Latin America Eye Drug Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Eye Drug Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Eye Drug Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Eye Drug Sales by Country (2015-2020) (MT)
Table 71. Middle East and Africa Eye Drug Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Eye Drug Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Eye Drug Revenue Market Share by Country (2015-2020)
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Business Overview
Table 76. Pfizer Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Pfizer Eye Drug Product
Table 78. Pfizer Recent Development
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Business Overview
Table 81. Novartis Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Novartis Product
Table 83. Novartis Recent Development
Table 84. bausch Lomb Corporation Information
Table 85. bausch Lomb Description and Business Overview
Table 86. bausch Lomb Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. bausch Lomb Product
Table 88. bausch Lomb Recent Development
Table 89. Laboratoire Riva Corporation Information
Table 90. Laboratoire Riva Description and Business Overview
Table 91. Laboratoire Riva Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Laboratoire Riva Product
Table 93. Laboratoire Riva Recent Development
Table 94. Jamp Pharma Corporation Information
Table 95. Jamp Pharma Description and Business Overview
Table 96. Jamp Pharma Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. Jamp Pharma Product
Table 98. Jamp Pharma Recent Development
Table 99. Fresenius Corporation Information
Table 100. Fresenius Description and Business Overview
Table 101. Fresenius Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. Fresenius Product
Table 103. Fresenius Recent Development
Table 104. Teva Pharmaceutical? Corporation Information
Table 105. Teva Pharmaceutical? Description and Business Overview
Table 106. Teva Pharmaceutical? Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 107. Teva Pharmaceutical? Product
Table 108. Teva Pharmaceutical? Recent Development
Table 109. SANDOZ Corporation Information
Table 110. SANDOZ Description and Business Overview
Table 111. SANDOZ Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. SANDOZ Product
Table 113. SANDOZ Recent Development
Table 114. Greenstone Corporation Information
Table 115. Greenstone Description and Business Overview
Table 116. Greenstone Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Greenstone Product
Table 118. Greenstone Recent Development
Table 119. Mylan Corporation Information
Table 120. Mylan Description and Business Overview
Table 121. Mylan Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Mylan Product
Table 123. Mylan Recent Development
Table 124. GE Medical Corporation Information
Table 125. GE Medical Description and Business Overview
Table 126. GE Medical Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 127. GE Medical Product
Table 128. GE Medical Recent Development
Table 129. Mint Pharmaceuticals Corporation Information
Table 130. Mint Pharmaceuticals Description and Business Overview
Table 131. Mint Pharmaceuticals Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 132. Mint Pharmaceuticals Product
Table 133. Mint Pharmaceuticals Recent Development
Table 134. Laboratoires Thea Corporation Information
Table 135. Laboratoires Thea Description and Business Overview
Table 136. Laboratoires Thea Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 137. Laboratoires Thea Product
Table 138. Laboratoires Thea Recent Development
Table 139. Taj Pharmaceuticals Corporation Information
Table 140. Taj Pharmaceuticals Description and Business Overview
Table 141. Taj Pharmaceuticals Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 142. Taj Pharmaceuticals Product
Table 143. Taj Pharmaceuticals Recent Development
Table 144. Actavis Corporation Information
Table 145. Actavis Description and Business Overview
Table 146. Actavis Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 147. Actavis Product
Table 148. Actavis Recent Development
Table 149. APOTEX Corporation Information
Table 150. APOTEX Description and Business Overview
Table 151. APOTEX Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 152. APOTEX Product
Table 153. APOTEX Recent Development
Table 154. Sun Pharma Corporation Information
Table 155. Sun Pharma Description and Business Overview
Table 156. Sun Pharma Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 157. Sun Pharma Product
Table 158. Sun Pharma Recent Development
Table 159. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 160. Key Challenges
Table 161. Market Risks
Table 162. Main Points Interviewed from Key Eye Drug Players
Table 163. Eye Drug Customers List
Table 164. Eye Drug Distributors List
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Eye Drug Product Picture
Figure 2. Global Eye Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Drops Product Picture
Figure 4. Tablet & Capsule Product Picture
Figure 5. Global Eye Drug Sales Market Share by Application in 2020 & 2026
Figure 6. Glaucoma
Figure 7. Retinal Disease
Figure 8. Bacterial?Infection
Figure 9. Other
Figure 10. Eye Drug Report Years Considered
Figure 11. Global Eye Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Eye Drug Sales 2015-2026 (MT)
Figure 13. Global Eye Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Eye Drug Sales Market Share by Region (2015-2020)
Figure 15. Global Eye Drug Sales Market Share by Region in 2019
Figure 16. Global Eye Drug Revenue Market Share by Region (2015-2020)
Figure 17. Global Eye Drug Revenue Market Share by Region in 2019
Figure 18. Global Eye Drug Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Eye Drug Revenue in 2019
Figure 20. Eye Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Eye Drug Sales Market Share by Type (2015-2020)
Figure 22. Global Eye Drug Sales Market Share by Type in 2019
Figure 23. Global Eye Drug Revenue Market Share by Type (2015-2020)
Figure 24. Global Eye Drug Revenue Market Share by Type in 2019
Figure 25. Global Eye Drug Market Share by Price Range (2015-2020)
Figure 26. Global Eye Drug Sales Market Share by Application (2015-2020)
Figure 27. Global Eye Drug Sales Market Share by Application in 2019
Figure 28. Global Eye Drug Revenue Market Share by Application (2015-2020)
Figure 29. Global Eye Drug Revenue Market Share by Application in 2019
Figure 30. Japan Eye Drug Sales Growth Rate 2015-2026 (MT)
Figure 31. Japan Eye Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. Japan Eye Drug Market Share in Global Market 2015-2026
Figure 33. Japan 5 and 10 Largest Eye Drug Players Market Share by Revenue in Eye Drug in 2019
Figure 34. Japan Eye Drug Revenue Share by Type (2015-2020)
Figure 35. Japan Eye Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 36. Japan Eye Drug Revenue Share by Application (2015-2020)
Figure 37. Japan Eye Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 38. North America Eye Drug Sales Growth Rate 2015-2020 (MT)
Figure 39. North America Eye Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Eye Drug Sales Market Share by Country in 2019
Figure 41. North America Eye Drug Revenue Market Share by Country in 2019
Figure 42. U.S. Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 43. U.S. Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 45. Canada Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Europe Eye Drug Sales Growth Rate 2015-2020 (MT)
Figure 47. Europe Eye Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Eye Drug Sales Market Share by Country in 2019
Figure 49. Europe Eye Drug Revenue Market Share by Country in 2019
Figure 50. Germany Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 51. Germany Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 53. France Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 55. U.K. Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 57. Italy Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 59. Russia Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Asia Pacific Eye Drug Sales Growth Rate 2015-2020 (MT)
Figure 61. Asia Pacific Eye Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Eye Drug Sales Market Share by Region in 2019
Figure 63. Asia Pacific Eye Drug Revenue Market Share by Region in 2019
Figure 64. China Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 65. China Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 67. Japan Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 69. South Korea Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 71. India Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 73. Australia Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 75. Taiwan Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 77. Indonesia Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 79. Thailand Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 81. Malaysia Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 83. Philippines Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 85. Vietnam Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Latin America Eye Drug Sales Growth Rate 2015-2020 (MT)
Figure 87. Latin America Eye Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Eye Drug Sales Market Share by Country in 2019
Figure 89. Latin America Eye Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 91. Mexico Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 93. Brazil Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 95. Argentina Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Middle East and Africa Eye Drug Sales Growth Rate 2015-2020 (MT)
Figure 97. Middle East and Africa Eye Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Eye Drug Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Eye Drug Revenue Market Share by Country in 2019
Figure 100. Turkey Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 101. Turkey Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 103. Saudi Arabia Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Eye Drug Sales Growth Rate (2015-2020) (MT)
Figure 105. U.A.E Eye Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Porter's Five Forces Analysis
Figure 107. Eye Drug Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs